Shamburg News · 8-K filed Nov 16, 2026, 5:06 PM EST
Aspira Women's Health to restate Q1 and Q2 2026 cash flow statements; reports material weakness
AWHL · Aspira Women's Health Inc.
- Financial statements
- Other event
- Materiality: high
On November 13, 2026, the Audit Committee of Aspira Women's Health Inc. concluded that previously issued unaudited financial statements for the three and six months ended March 31 and June 30, 2026 should no longer be relied upon due to material errors in the Statement of Cash Flows. The errors involved classification of a January 2026 Agile loan and related payments, which were reported in operating rather than financing activities; the restatement does not affect the balance sheet, statements of operations, or total net change in cash. The Company plans to restate the affected Form 10-Q filings and has concluded a material weakness in internal control over financial reporting exists, with disclosure controls and internal control deemed ineffective.
Source: SEC EDGAR, Form 8-K, Item 4.02, accession 0000926617-26-000058.
Written from the filing by Shamburg Markets. Figures are as reported by the company.